Lyra Therapeutics (LYRA) Q3 2023 Earnings

7NovConfirmed
Nov 22
Q4 2022
Q2 2023
Q3 2023
-0.44
-0.38
-0.33
-0.27

Details

Expected EPS
-0.32
Actual EPS
-0.27
Surprise EPS
0.05
Surprise Percent
+15.62%

Description

Lyra Therapeutics (LYRA) has reported earnings of -0.27 per share for Q3 2023.

0 Comments

Share your thoughts